XXII

22nd Century Group, Inc.

Nasdaq · Cigarettes · Inc. FL · CIK 0001347858
$0.5160 +11.45% $2.3M
High Impact Filing (7/10)
Vol
Market Cap$2.3M
Cap SizeNano Cap
SEC Reports5
Exchange Nasdaq·Sector Cigarettes·Inc. FL·CIK 0001347858·Prev Close $0.4630

Price Targets

Historical data — last covering-analyst action Aug 2023. No current recommendation available.
$135.00 (Aug 2023)
Current $0.5970 Low $135.00 Median $135.00 High $135.00 1 analysts
$135.00 $135.00

Analyst Ratings

Historical distribution86% buy · 7 analysts · last covering-analyst action Aug 2023
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Aug 23, 2023 Roth MKM REITERATE Buy → Buy
Aug 17, 2023 Alliance Global Partners DOWNGRADE Buy → Neutral
Aug 15, 2023 Dawson James MAINTAIN Buy → Buy
Aug 15, 2023 TD Cowen DOWNGRADE Outperform → Market Perform
Jul 3, 2023 Dawson James MAINTAIN Buy → Buy

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Aug 2023): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Aug 2023. No current recommendation available.
$135.00 mean target (Aug 2023)
$135.00 Low $135.00 High
MetricValue
Current Price$0.5970
Target Low$135.00
Target Mean$135.00
Target Median$135.00
Target High$135.00
# Analysts1
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2026-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
4 analyst firms have rated this stock: 0 upgrades, 2 downgrades, 0 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Aug 23, 2023 Roth MKM REITERATE Buy Buy
Aug 17, 2023 Alliance Global Partners DOWNGRADE Buy Neutral
Aug 15, 2023 Dawson James MAINTAIN Buy Buy
Aug 15, 2023 TD Cowen DOWNGRADE Outperform Market Perform
Jul 3, 2023 Dawson James MAINTAIN Buy Buy
Mar 4, 2022 Dawson James MAINTAIN Buy Buy
Feb 24, 2022 Dawson James MAINTAIN Buy Buy
Feb 16, 2022 Dawson James MAINTAIN Buy Buy
Jan 24, 2022 Dawson James MAINTAIN Buy Buy
Jan 6, 2022 Dawson James MAINTAIN Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20262410086%
May 1, 20262410086%
Apr 1, 20262410086%
Mar 1, 20262410086%
Feb 1, 20262410086%
Jan 1, 20262410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 9, 2026
short_volume
Short Volume: XXII — 71.9% short (0.4M / 0.5M)
Short: 390,968 | Exempt: 75,532 | TRF Vol: 543,952 | Short Ratio: 71.9% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: XXII — 58.2% short (0.4M / 0.7M)
Short: 378,329 | Exempt: 83,734 | TRF Vol: 650,348 | Short Ratio: 58.2% | Off-exchange volume (dark pool + OTC)
May 15, 2026
other
22nd Century Group (Nasdaq: XXII) Ignites Major VLN® Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle Brand
<p align="justify"><i>VLN<sup>®</sup> Product Launch in Over 150 New High-Visibility Store Locations Positions XXII to Introduce VLN<sup>®</sup> to Ne
May 12, 2026
other
22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review
<p><i>FDA filing covers renewal applications for VLN<sup>®</sup> King and VLN<sup>®</sup> Menthol King, the first combusted cigarettes authorized as M
May 11, 2026
earnings_calendar
XXII Q1 2026 Earnings Scheduled — 2026-05-11
May 7, 2026
earnings
22nd Century Group Reports First Quarter 2026 Financial Results
<p align="justify"><i>Continues VLN</i><sup>®</sup><i> Commercial Expansion with New Stores Selling Proprietary Branded VLN</i><sup>®</sup><i> Product
May 5, 2026
short_volume
Short Volume: XXII — 58.9% short (0.4M / 0.6M)
Short: 355,758 | Exempt: 32,819 | TRF Vol: 603,505 | Short Ratio: 58.9% | Off-exchange volume (dark pool + OTC)
May 4, 2026
short_volume
Short Volume: XXII — 56.2% short (1.0M / 1.8M)
Short: 1,035,255 | Exempt: 129,620 | TRF Vol: 1,843,699 | Short Ratio: 56.2% | Off-exchange volume (dark pool + OTC)
May 4, 2026
short_interest
FTD: XXII — 494,529 shares ($0.7M) failed to deliver
Settlement: 20260504, Price: $1.37, FTD Value: $677,504.73, 22ND CENTY GROUP INC COM PAR $
Apr 29, 2026
other
22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership
<p align="justify"><i>Chairman &amp; CEO Larry Firestone Details 2026 Priorities and Shareholder Value Strategy</i></p>
Apr 23, 2026
other
22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University
<p align="justify"><b>MOCKSVILLE, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- </b>22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company f
Mar 26, 2026
earnings
22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results
<p align="justify"><i>VLN</i><sup>®</sup><i> Commercial Expansion Drives Continued Shift Toward Higher Margin Proprietary Branded Products</i></p>
Mar 18, 2026
earnings_calendar
XXII Q4 2025 Earnings After Market Close — 2026-03-18